JPMorgan Chase & Co. Reaffirms “Buy” Rating for AXA (CS)
JPMorgan Chase & Co. reissued their buy rating on shares of AXA (EPA:CS) in a research note issued to investors on Wednesday, January 3rd. JPMorgan Chase & Co. currently has a price target on the stock.
Other analysts also recently issued reports about the company. Barclays set a €27.50 ($33.95) price target on AXA and gave the company a buy rating in a research report on Wednesday, October 25th. Deutsche Bank set a €27.50 ($33.95) price target on AXA and gave the company a buy rating in a research report on Monday, October 9th. Kepler Capital Markets set a €29.80 ($36.79) price target on AXA and gave the company a buy rating in a research report on Thursday, September 28th. Royal Bank of Canada set a €28.00 ($34.57) price target on AXA and gave the company a buy rating in a research report on Wednesday, September 13th. Finally, Baader Bank set a €27.00 ($33.33) price target on AXA and gave the company a buy rating in a research report on Friday, November 3rd. Four investment analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. AXA presently has a consensus rating of Buy and a consensus target price of €28.07 ($34.65).
AXA (EPA:CS) traded up €0.25 ($0.31) during mid-day trading on Wednesday, hitting €27.17 ($33.54). The stock had a trading volume of 4,370,000 shares, compared to its average volume of 5,510,000. The company has a market capitalization of $65,910.00 and a price-to-earnings ratio of 11.56. AXA has a 52 week low of €21.81 ($26.93) and a 52 week high of €27.69 ($34.19).
AXA SA (AXA) is a France-based holding company engaged in the business of financial protection. The Company’s segments include Life & Savings, Property & Casualty, Asset Management , Banking and Holding companies. The Life & Savings segment’s products include a range of investment and savings products, as well as Protection and Health products.
Receive News & Ratings for AXA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AXA and related companies with MarketBeat.com's FREE daily email newsletter.